Viridian Therapeutics Ors Inc (VRDN)
Cash & Short-Term Investments
$981.53M
Quarterly · Period ending: · USD
VRDN Cash & Short-Term Investments
Latest reported$981.53Mperiod ending
Latest reported$981.53Mperiod ending
VRDN Quarterly Cash & Short-Term Investments ($209.35K → $981.53M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
VRDN cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 981,530,000 | |
| 762,181,000 | |
| 874,652,000 | |
| 490,901,000 | |
| 563,356,000 | |
| 636,633,000 | |
| 717,584,000 | |
| 753,240,000 | |
| 571,366,000 | |
| 613,187,000 | |
| 477,370,000 | |
| 313,007,000 | |
| 334,291,000 | |
| 373,858,000 | |
| 424,550,000 | |
| 431,322,000 | |
| 161,207,000 | |
| 175,428,000 | |
| 196,965,000 | |
| 213,812,000 | |
| 109,301,000 | |
| 117,100,000 | |
| 127,639,000 | |
| 30,079,000 | |
| 30,582,000 | |
| 36,103,000 | |
| 26,845,000 | |
| 33,838,000 | |
| 43,947,000 | |
| 51,039,000 | |
| 62,481,000 | |
| 70,527,000 | |
| 76,262,000 | |
| 78,099,000 | |
| 47,441,000 | |
| 42,805,000 | |
| 46,335,000 | |
| 54,273,000 | |
| 3,341,000 | |
| 5,351,000 | |
| 6,501,000 | |
| 8,560,000 | |
| 10,832,000 | |
| 12,124,000 | |
| 10,448,000 | |
| 13,268,000 | |
| 5,119,000 | |
| 6,388,358 | |
| 7,696,325 | |
| 105,105 | |
| 209,348 |